Marcel van den Brink, President of City of Hope, shared a post on LinkedIn:
“At City of Hope, we are driven by a commitment to bring the most advanced cancer care to every patient, no matter where they live. Today, I’m proud to share a groundbreaking step forward in that mission.
We’ve launched a transformative national clinical trials model, a new framework that enables us to open trials simultaneously across multiple states, accelerating access to promising therapies and expanding equity in cancer research.
Too often, access to clinical trials is determined by geography. Our new approach ensures that patients in underserved communities can benefit from the same cutting-edge treatments as those near major academic centers.
This is what it means to make hope a reality – not just for some, but for all.”
More posts featuring Marcel van den Brink on OncoDaily.